Mirae Asset Global Investments’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Buy |
16,316
+746
| +5% | +$21.2K | ﹤0.01% | 954 |
|
|
2025
Q1 | $492K | Buy |
15,570
+11,594
| +292% | +$366K | ﹤0.01% | 930 |
|
|
2024
Q4 | $120K | Sell |
3,976
-260
| -6% | -$7.83K | ﹤0.01% | 1122 |
|
|
2024
Q3 | $179K | Buy |
4,236
+1,381
| +48% | +$58.5K | ﹤0.01% | 1102 |
|
|
2024
Q2 | $116K | Sell |
2,855
-34,607
| -92% | -$1.4M | ﹤0.01% | 1122 |
|
|
2024
Q1 | $798K | Sell |
37,462
-128,557
| -77% | -$2.74M | ﹤0.01% | 1656 |
|
|
2023
Q4 | $1.5M | Buy |
166,019
+124,633
| +301% | +$1.13M | ﹤0.01% | 1398 |
|
|
2023
Q3 | $264K | Sell |
41,386
-7,981
| -16% | -$50.9K | ﹤0.01% | 2190 |
|
|
2023
Q2 | $547K | Buy |
49,367
+6,904
| +16% | +$76.6K | ﹤0.01% | 1903 |
|
|
2023
Q1 | $652K | Buy |
42,463
+17,241
| +68% | +$265K | ﹤0.01% | 1799 |
|
|
2022
Q4 | $560K | Buy |
25,222
+3,407
| +16% | +$75.6K | ﹤0.01% | 1829 |
|
|
2022
Q3 | $356K | Buy |
21,815
+9,729
| +80% | +$159K | ﹤0.01% | 2074 |
|
|
2022
Q2 | $175K | Buy |
+12,086
| New | +$175K | ﹤0.01% | 2184 |
|